GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tonix Pharmaceuticals Holding Corp (STU:TPM0) » Definitions » Shiller PE Ratio

Tonix Pharmaceuticals Holding (STU:TPM0) Shiller PE Ratio : (As of Jun. 08, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Tonix Pharmaceuticals Holding Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Tonix Pharmaceuticals Holding Shiller PE Ratio Historical Data

The historical data trend for Tonix Pharmaceuticals Holding's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonix Pharmaceuticals Holding Shiller PE Ratio Chart

Tonix Pharmaceuticals Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Tonix Pharmaceuticals Holding Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Tonix Pharmaceuticals Holding's Shiller PE Ratio

For the Biotechnology subindustry, Tonix Pharmaceuticals Holding's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tonix Pharmaceuticals Holding's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tonix Pharmaceuticals Holding's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Tonix Pharmaceuticals Holding's Shiller PE Ratio falls into.



Tonix Pharmaceuticals Holding Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Tonix Pharmaceuticals Holding's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Tonix Pharmaceuticals Holding's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-5.299/131.7762*131.7762
=-5.299

Current CPI (Mar. 2024) = 131.7762.

Tonix Pharmaceuticals Holding Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -4,448,384.000 100.560 -5,829,296.483
201409 -5,757,144.000 100.428 -7,554,228.602
201412 -7,290,079.000 99.070 -9,696,798.399
201503 -4,472,622.000 99.621 -5,916,268.052
201506 -5,240,416.500 100.684 -6,858,714.976
201509 -5,902,875.000 100.392 -7,748,249.967
201512 -6,132,240.000 99.792 -8,097,643.555
201603 -6,275,224.000 100.470 -8,230,535.291
201606 -2,909,116.300 101.688 -3,769,883.510
201609 -1,687,999.500 101.861 -2,183,742.156
201612 -1,182,156.000 101.863 -1,529,313.728
201703 -789,140.000 102.862 -1,010,962.924
201706 -386,745.050 103.349 -493,122.756
201709 -441,314.000 104.136 -558,451.499
201712 -386,798.750 104.011 -490,052.210
201803 -468,690.687 105.290 -586,594.843
201806 -400,805.736 106.317 -496,785.615
201809 -293,469.366 106.507 -363,097.137
201812 -190,813.320 105.998 -237,218.419
201903 -58,065.293 107.251 -71,343.478
201906 -52,206.062 108.070 -63,658.261
201909 -28,930.514 108.329 -35,192.230
201912 -7,549.065 108.420 -9,175.301
202003 -2,143.040 108.902 -2,593.184
202006 -1,307.136 108.767 -1,583.651
202009 -489.024 109.815 -586.821
202012 -526.080 109.897 -630.817
202103 -376.320 111.754 -443.741
202106 -373.500 114.631 -429.362
202109 -272.000 115.734 -309.702
202112 -396.480 117.630 -444.163
202203 -292.376 121.301 -317.625
202206 -231.278 125.017 -243.783
202209 -137.037 125.227 -144.204
202212 -105.728 125.222 -111.262
202303 -95.940 127.348 -99.276
202306 -79.156 128.729 -81.030
202309 -54.871 129.860 -55.681
202312 -13.678 129.419 -13.927
202403 -5.299 131.776 -5.299

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Tonix Pharmaceuticals Holding  (STU:TPM0) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Tonix Pharmaceuticals Holding Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Tonix Pharmaceuticals Holding's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tonix Pharmaceuticals Holding (STU:TPM0) Business Description

Traded in Other Exchanges
Address
26 Main Street, Suite 101, Chatham, NJ, USA, 07928
Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on developing therapeutics and vaccines to treat and prevent human disease and alleviate suffering. its portfolio consists of the central nervous system, rare disease, immunology, and infectious disease product candidates. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. CNS product candidate is TNX-102 SL, a proprietary sublingual tablet formulation of cyclobenzaprine (CBP) designed for bedtime administration.

Tonix Pharmaceuticals Holding (STU:TPM0) Headlines

No Headlines